EXPANDED PHARMA SOLUTIONS AT BIO ASIA-TAIWAN 2026
Bringing new global partners for Taiwan’s thriving pharmaceutical and biotechnology industry
Rieckermann successfully participated in BIO Asia-Taiwan 2026, one of the region’s leading events for the pharmaceutical, biotechnology, and life sciences sectors. This year, the company highlighted solutions from their long-standing global technology partners such as Glatt, Korsch, Harro Höfliger, NIKKA Densok, Sensum, and more.
In addition, Rieckermann introduced several newly added partners in their expanded life science portfolio—which was a major highlight for their exhibition. These included esteemed technology providers such as Alexanderwerk, IWK, Orise, Protak, TRM Filter, and Welkin.
Together, these partners offer innovative technologies that support efficient, high-quality pharmaceutical production across a range of applications. New capabilities are also now available, including:
- Dry granulation technologies
- Tube filling solutions
- Bio decontamination validation
- Dust extraction systems
- Clean fluid handling technologies
- Digital smart manufacturing solutions
This expansion further strengthen Rieckermann’s ability to support pharmaceutical and biotechnology manufacturers with integrated solutions that enhance productivity, quality, compliance, and operational efficiency.
Throughout the exhibition, the team welcomed a strong turnout of visitors and engaged in meaningful discussions with professionals from across Taiwan’s pharmaceutical and biotech sectors. The high level of interest demonstrated the industry’s continued investment in innovation, advanced manufacturing technologies, and future-ready production capabilities.
BIO Asia-Taiwan was held from July 16 to 19, 2026, at the Taipei Nangang Exhibition Center, serving as a key meeting point for industry networking, knowledge exchange, and the exploration of emerging technologies and partnerships across Asia. The positive response received during the event reinforces Rieckermann’s confidence in the long-term growth potential of Taiwan’s life sciences market and their commitment to supporting customers with world-class technologies and local expertise.
